Maipu Medical: Announcement on Participating in the 2024 Online Group Reception Day for Investors of Listed Companies in Guangdong
Medprin Regenerative Medical Technologies: Investor relations activity record form, August 19, 2024.
Medprin Regenerative Medical Technologies: Huatai United Securities Co., Ltd.'s continuous supervision and follow-up report on the first half of 2024 for Guangzhou Mike Bio-Regenerative Medical Technology Co., Ltd.
Medprin Regenerative Medical Technologies: Verification opinion of the listing of restricted shares of Guangzhou Maipep Regenerative Medical Technology Co., Ltd.'s initial public offering by Huatai United Securities Co., Ltd.
Medprin Regenerative Medical Technologies: Announcement of Resolutions from the Third Session of the Third Board of Directors
Medprin Regenerative Medical Technologies: Independent financial advisor report on the first grant of Guangzhou Maple Resurrection Medical Technology Co., Ltd.'s 2024 Restricted Stock Incentive Plan, by Shanghai Xingongyihe Enterprise Management Consulting Co., Ltd.
Medprin Regenerative Medical Technologies: Announcement of Resolutions of the Third Meeting of the Third Supervisory Committee
Medprin Regenerative Medical Technologies: Investor Relations Activity Record Form - July 10, 2024
Medprin Regenerative Medical Technologies: Investor Relations Activity Record Form for July 1, 2024
Medprin Regenerative Medical Technologies: Announcement of resolutions of the second meeting of the third board of directors.
Medprin Regenerative Medical Technologies: Assessment and Management Measures for the Implementation of Restricted Stock Incentive Plan of Guangzhou Maipu Regenerative Medical Technology Co., Ltd. in 2024.
Medprin Regenerative Medical Technologies: Announcement of the Resolutions of the Second Meeting of the Third Session of the Supervisory Board.
Medprin Regenerative Medical Technologies: Independent financial advisor report on 2024 Restricted Stock Incentive Plan (Draft) of Guangzhou Maipu Regenerative Medical Technology Co., Ltd. by Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd.
Medprin Regenerative Medical Technologies: Independent financial advisor report on matters related to the reserved granting of restricted stock incentives for Guangzhou Mapei Regenerative Medical Technology Co., Ltd.'s 2023 plan, as commissioned by Shanghai Xingong YI He Enterprise Management Consulting Co., Ltd.
Medprin Regenerative Medical Technologies: Investor Relations Activity Record June 19, 2024
Medprin Regenerative Medical Technologies: May 16, 2024 Investor Relations Activity Record
Medprin Regenerative Medical Technologies: Huatai United Securities Co., Ltd. inspection opinions on the 2023 internal control self-evaluation report of Guangzhou Maipu Regenerative Medicine Technology Co., Ltd.
Medprin Regenerative Medical Technologies: Huatai United Securities Co., Ltd.'s 2023 continuous follow-up report on Guangzhou Maipu Regenerative Medicine Technology Co., Ltd.
Medprin Regenerative Medical Technologies: Announcement of Resolutions of the First Meeting of the Third Board of Supervisors
Medprin Regenerative Medical Technologies: Announcement of Resolutions of the First Meeting of the Third Board of Directors
No Data